Results 101 to 110 of about 29,702 (243)
The Use of Public Health Evidence in Whole Woman’s Health v Hellerstedt [PDF]
, 2016 [This piece, written for the JAMA Internal Medicine "Viewpoints" section, discusses the impacts of House Bill 2, as documented by TxPEP research, and the use of research-based evidence in Whole Woman's Health v Hellerstedt.] The Supreme Court decision in
Grossman, D.
core +1 more source
International Journal of Cancer, Volume 158, Issue 6, Page 1740-1754, 15 March 2026.What's new? In addition to governing daily variations in biological activity, the circadian clock regulates immune cell migration into tumors. Whether this influence extends to immune cell localization within the tumor microenvironment (TME) is unknown. Here, using cell and animal models, the authors investigated immune cell distribution within the TME
Akito Tsuruta +10 more
wiley +1 more source
Women's Health ReportsBackground: About 25% of pregnancies end in early miscarriage or abortion annually in the United States. While mifepristone is part of the most effective medication regimen for miscarriage and abortion, regulatory burdens and legal restrictions limit its
Emily Newton-Hoe +4 more
doaj +1 more source
Cervical preparation for first trimester surgical abortion. [PDF]
, 2010 BACKGROUND: Preparing the cervix prior to surgical abortion is intended to make the procedure both easier and safer. Options for cervical preparation include osmotic dilators and pharmacologic agents.
Hayes, Jennifer L +3 more
core +1 more source
Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing’s Syndrome
Case Reports in Endocrinology, 2016 A 30-year-old Caucasian man presented with severe Cushing’s syndrome (CS) resulting from ectopic adrenocorticotropin syndrome (EAS) from a metastatic pancreatic neuroendocrine tumor.
Andreas G. Moraitis, Richard J. Auchus
doaj +1 more source
ALTERNATIVE APPROACHES TO MEDICAL ABORTION [PDF]
Trakia Journal of SciencesMedical abortion involving various pharmacological agents has demonstrated high levels of complete uterine evacuation. Alternative approaches involving letrozole, mifepristone, methotrexate used synergically with misoprostol are non-invasive elective ...
K. Telbiyska, M. Angelova
doaj +1 more source
Clinical Endocrinology, Volume 104, Issue 3, Page 215-221, March 2026.ABSTRACT Objective Mild autonomous cortisol secretion (MACS) is associated with increased cardiometabolic risk factors including hypertension, type 2 diabetes and dyslipidaemia. By using evening doses of metyrapone, a short‐acting 11‐β hydroxylase inhibitor, it has been shown that it is possible to reset the abnormal circadian cortisol rhythm in MACS ...
Simon Berry +3 more
wiley +1 more source
Reproductive outcomes following surgical removal of uterine fibroids
Медицинский совет, 2019 The cohort prospective comparative study investigated the efficacy of mifepristone use in patients after surgical treatment of uterine myoma. It was shown that the use of mifepristone at a dose of 50 mg/day in a continuous mode for 3 months after ...
A. E. Mitichkin +7 more
doaj +1 more source
Journal of Advanced Nursing, Volume 82, Issue 3, Page 2152-2164, March 2026.ABSTRACT Aim To examine practice nurse knowledge, attitudes, and practices about medication abortion in Australia. Design Cross‐sectional survey. Methods A national online survey was conducted from July to December 2021. Nurses working in general practice were recruited using convenience sampling.
Sharon James +7 more
wiley +1 more source